Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricDVADaVitaLHLabcorpDGXQuest Diagnostics
Snapshot
Price$180.54$318.21$238.28
Market cap$15.08B$23.53B$23.88B
Valuation
P/E14.9x27.8x25.7x
Forward P/E13.9x21.3x22.3x
Growth
Revenue growth6.7%7.3%11.0%
EPS growth6.6%30.2%14.9%
Profitability
Net margin5.7%6.7%9.1%
ROE181.2%10.9%14.1%
Balance sheet & cash
Debt / equity77.99x0.66x0.82x
Free cash flow yield8.2%5.2%5.4%
Dividend yield—1.1%1.7%
Verdict
Investment ratingNeutral· 53Neutral· 52Neutral· 52

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearDVAtoday $181LHtoday $318DGXtoday $238
2027$144.36 – $211.72+17% CAGR$310.64 – $455.60+43% CAGR$205.30 – $301.11+26% CAGR
2028$153.90 – $225.72+12% CAGR$404.32 – $593.01+37% CAGR$235.85 – $345.91+20% CAGR
2029$164.07 – $240.64+10% CAGR$526.27 – $771.86+34% CAGR$270.95 – $397.39+19% CAGR
2030$174.91 – $256.54+9% CAGR$684.99 – $1,004.65+33% CAGR$311.26 – $456.52+18% CAGR
2031$186.48 – $273.50+9% CAGR$891.59 – $1,307.66+33% CAGR$357.58 – $524.45+17% CAGR
5-yr CAGR0.6% – 8.7%22.9% – 32.7%8.5% – 17.1%